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Abstract: Dinoflagellates are not only important marine primary producers and grazers, 
but also the major causative agents of harmful algal blooms. It has been reported that 
many dinoflagellate species can produce various natural toxins. These toxins can be 
extremely toxic and many of them are effective at far lower dosages than conventional 
chemical agents. Consumption of seafood contaminated by algal toxins results in various 
seafood poisoning syndromes: paralytic shellfish poisoning (PSP), neurotoxic shellfish 
poisoning (NSP), amnesic shellfish poisoning (ASP), diarrheic shellfish poisoning (DSP), 
ciguatera fish poisoning (CFP) and azaspiracid shellfish poisoning (ASP). Most of these 
poisonings are caused by neurotoxins which present themselves with highly specific 
effects on the nervous system of animals, including humans, by interfering with nerve 
impulse transmission. Neurotoxins are a varied group of compounds, both chemically 
and pharmacologically. They vary in both chemical structure and mechanism of action, 
and produce very distinct biological effects, which provides a potential application of 
these toxins in pharmacology and toxicology. This review summarizes the origin, 
structure and clinical symptoms of PSP, NSP, CFP, AZP, yessotoxin and palytoxin 
produced by marine dinoflagellates, as well as their molecular mechanisms of action on 
voltage-gated ion channels. 
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1. Introduction 
Over the past few decades, the occurrence of harmful algal blooms (HABs) has increased both in 
frequency and in geographic distribution in many regions of the world. This has resulted in adverse 
impacts on public health and the economy, and has become a global concern [1-3]. It is known that 
certain HAB species can produce potent toxins that impact human health through the consumption of 
contaminated shellfish, coral reef fish and finfish, or through water or aerosol exposure [4]. In many 
cases, toxic species are normally present in low concentrations with no environmental or human health 
impacts. However, when they are present at high cell density and are ingested by filter-feeding 
shellfish, zooplankton, and herbivorous fishes, toxins are accumulated in these organisms and 
transferred to higher trophic levels through the food chain, which results in various adverse effects. It 
is reported that algal toxins result in more than 50,000-500,000 intoxication incidents per year, with an 
overall mortality rate of 1.5% on a global basis [5]. In addition to their adverse effects on human health, 
algal toxins are responsible for the death of fish and shellfish and have caused episodic mortalities of 
marine mammals, birds, and other animals depending on the marine food web [6-9]. 
Of those causative organisms, dinoflagellates, a very large and diverse group of eukaryotic algae in 
the marine ecosystem, are the major group producing toxins that impact humans [4, 10]. Dinoflagellate 
toxins are structurally and functionally diverse, and many present unique biological activities. In the 
past few decades, extensive studies have been devoted to the toxicology and pharmacology of 
dinoflagellate toxins [11], and five major seafood poisoning syndromes caused by toxins have been 
identified from the dinoflagellates (Table 1): paralytic shellfish poisoning (PSP), neurotoxic shellfish 
poisoning (NSP), amnesic shellfish poisoning (ASP), diarrheic shellfish poisoning (DSP) and ciguatera 
fish poisoning (CFP). Besides these well-known poisonings, several new poisoning syndromes 
resulting from newly appearing dinoflagellate toxins, such as azaspiracid toxins, yessotoxin and 
palytoxin have been reported and characterized recently (Table 1), and this has increased global public 
concerns regarding dinoflagellate associated toxins. Dinoflagellate toxins can be functionally 
categorized as neurotoxins and hepatotoxins, according to their clinical symptoms. The neurotoxicity 
of dinoflagellate toxins is mediated by diverse, highly specific interactions with ion channels involved 
in neurotransmission (Figure 1). This paper provides a brief overview of the origin, structure and 
clinical symptoms of PSP, NSP, CFP, AZP, yessotoxin and palytoxin produced by dinoflagellates as 
well as their molecular mechanisms of action on voltage-gated ion channels. 
2. Voltage-gated ion channels and neurotoxins 
It is known that most dinoflagellate toxins are neurotoxins, which interact with the specific 
receptors associated with neurotransmitter receptors, or voltage-sensitive ion channels (Figure 1), 
resulting in the observed neurotoxicity [12]. In organisms including humans, voltage-gated ion 
channels, such as sodium, calcium, and potassium channels, are electrical signal generators which 
control contraction of muscle, secretion of hormones, sensing of the environment, processing of 
information in the brain, and output from the brain to peripheral tissues [13]. These channels share a 
common structural motif containing six transmembrane segments (S1-S6) and a pore loop (Figure 1). 
The voltage sensor domain consists of the S1-S4 segments with positively charged residues in the S4 
segment as gating charges, while the pore is composed of the S5/S6 segments and the pore loop 
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between them, which are gated by bending of the S6 segment at a hinge glycine or praline residue. In 
all of these contexts, electrical signals are conducted by members of the ion channel protein super 
family, a set of more than 140 structurally related pore-forming proteins [14]. Pharmacological studies 
have disclosed that the functions of the voltage-gated ion channel proteins can be classified into three 
complementary aspects: ion conductance, pore gating and regulation. These channel proteins are the 
molecular targets for a broad range of potent neurotoxins, which strongly alter channel functions by 
binding to specific receptor sites. At present, six different neurotoxin receptor sites on the channel 
protein have been identified on voltage-gated ion channels using various neurotoxins [15-19]. 
Hydrophilic low molecular mass toxins and large polypeptide toxins block the channel pore physically 
and prevent ion conductance. Alkaloid toxins and related lipid soluble toxins alter voltage-dependent 
gating through binding to intramembranous receptor sites. On the contrary, poplypeptide toxins alter 
channel gating through binding to extracellular sites [20, 13]. In the section below we describe the 
molecular mechanisms of action of seven different neurotoxins produced by dinoflagellates. 
Table 1. Seafood poisonings caused by neurotoxins identified from marine dinoflagellate species. 
Type of 
poisoning 
Toxins Sources of toxins Primary 
vector 
Action target Ref. 
PSP Saxitoxins and 
gonyautoxins 
Alexandrium spp., 
Gymnodinium spp., 
Pyrodinium spp. 
Shellfish Voltage-gated 
sodium channel 1 
23, 27-29 
NSP Brevetoxins Kerenia brevis, 
Chatonella marina, 
C. antiqua, 
Shellfish Voltage-gated 
sodium channel 5 
33, 
39-41, 
46, 52 
  Fibrocapsa 
japonica, 
Heterosigma 
akashiwo 
   
 Yessotoxins Protoceratium 
reticulatum, 
Lingulodinium 
polyedrum 
Shellfish Voltage-gated 
calcium/sodium 
channel? 
94-95 
  Gonyaulax spinifera    
CFP Ciguatoxins Gambierdiscus 
toxicus 
Coral 
reef fish 
Voltage-gated 
sodium channel 5 
55, 62, 63 
CFP Maitotoxins Gambierdiscus 
toxicus 
Coral 
reef fish 
Voltage-gated 
calcium channel 
69, 70 
AZP Azaspiracids Protoperidinium 
crassipes 
Shellfish Voltage-gated 
calcium channel 
72, 76 
Palytoxin 
poisoning 
Palytoxins Ostrepsis siamensis Shellfish Na+-K+ ATPase 97, 
109-111 
Notes: PSP, paralytic shellfish poisoning; NSP, neurotoxic shellfish poisoning; CFP, ciguatera 
fish poisoning, AZP, azaspiracid poisoning. 
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Figure 1. The voltage-gated channels: The different members of the ion channel family 
structurally related to the voltage-gated ion channels are illustrated as transmembrane 
folding diagrams in which cylinders represent probable transmembrane alpha helices. 
Green, S5-S6 pore forming segments; red, S4 voltage sensor; and gray, S1-S3 
tansemembrane segments [13]. 
 
3. Paralytic shellfish poisoning (PSP) 
PSP is a worldwide marine toxin disease with both neurologic and gastrointestinal symptoms, 
which is caused by the consumption of shellfish contaminated by toxic dinoflagellates [21]. The first 
PSP event was reported in 1927 near San Francisco, USA, and was caused by a dinoflagellate, A. 
catenella, which resulted in 102 people being ill and six deaths [22]. Since then, members of three 
dinoflagellate genera have been reported to be the major sources of PSP toxins: Alexandrium, 
Gymnodinium, and Pyrodinium [23]. Paralytic shellfish toxins (PSTs) are produced in varying 
proportions by different dinoflagellate species and even by different isolates within a species. PSP 
toxins are heat-stable and water-soluble nonproteinaceous toxins. The basic structures of PSP toxins 
are 3,4-propinoperhydropurine tricyclic systems. Saxitoxin and its analogues can be divided into three 
categories: the carbamate compounds, which include saxitoxin, neo-saxitoxin and gonyautoxins 1-4; 
the N-sulfocarbamoyl compounds, which include the C and B toxins; and finally the decarbamoyl 
compounds with respect to the presence or absence of 1-N-hydroxyl, 11-hydroxysulfate, and 
21-N-sulfocarbamoyl substitutions as well as epimerization at the C-11 position (Figure 2). In the past 
few decades at least 24 structurally related imidazoline guanidinium PSP derivatives have been 
identified and characterized from dinoflagellate species [21, 24]. 
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Figure 2. Structure and species of paralytic shellfish poisoning toxins from marine 
dinoflagellates [4]. 
N
N
N
H
H
N
R3 R2
OH
OH
NH2
R1
H2N
1
2 3 4
5
6 7
8
9
10 12
11
13
14
15
16
17
R4
 
 Toxin R1 R2 R3 R4 
 STX H H H OCONH2 
 Neo STX OH H H OCONH2 
 GTX1 OH OSO3- H OCONH2 
Carbamate GTX2 H OSO3- H OCONH2 
 GTX3 H H OSO3- OCONH2 
 GTX4 OH H OSO3- OCONH2 
 GTX5(B1) H H H OCONHSO3- 
 GTX6(B2) OH H H OCONHSO3- 
 C1 H OSO3- H OCONHSO3- 
N-sulfocarbamoyl C2 H H OSO3- OCONHSO3- 
 C3 OH OSO3- H OCONHSO3- 
 C4 OH H OSO3- OCONHSO3- 
 dcSTX H H H OH 
 dcNeoSTX OH H H OH 
 dcGTX1 OH OSO3- H OH 
Decarbamoyl dcGTX2 H OSO3- H OH 
 dcGTX3 H H OSO3- OH 
 dcGTX4 OH H OSO3- OH 
 doSTX H H H H 
Deoxydecarbamoyl doGTX2 H H OSO3- H 
 doGTX3 H OSO3- H H 
 
Saxitoxin is the most toxic and also the most well studied among the PSP associated toxins. In mice, 
its LD50 peritoneal is 3-10 μg/kg body weight and orally is 263 μg/kg body weight. The lethal oral 
dose in humans is 1 to 4 mg (5,000 to 20,000 mouse units), depending on the gender and physiological 
condition of the patient. It is rapidly absorbed through the gastrointestinal tract and excreted in the 
urine. The symptoms of PSP include a tickling sensation of the lips, mouth and tongue, numbness of 
the extremities, gastrointestinal problems, difficulty in breathing, and a sense of dissociation followed 
by complete paralysis [25]. In the case of serious intoxication, PSP leads to a variety of neurological 
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symptoms culminating in respiratory arrest and cardiovascular shock or death [26]. Saxitoxin and its 
analogues are very dangerous compounds, with possible military potential and have been listed by the 
Organization for the Prohibition of Chemical Weapons (OPCW) as a Schedule 1 chemical intoxicant, 
the manufacture, use, transfer and reuse of which are now strictly regulated by the OPCW (Chemical 
Weapons Convention, September 1998, The Hague, Netherlands). 
PSP toxins are the most well known potent neurotoxins that specifically and selectively bind the 
sodium channels on excitable cells [27]. In 1975, Hill postulated a plugging model for the binding of 
the sodium channel with saxitoxin [28]. In this model, the toxin molecular penetrates rather deeply 
inside the channel and plugs it, having formed an ion pair with an anionic site thought to be located 
near the bottom of the channel. However, this model could not explain the lack of anticipated steric 
interactions with other structurally unfolded toxins, the gonyautoxins. Later, Kao and Walker proposed 
a model which placed the toxin molecules on the outside edge of the channel with the guanidinium 
group on the top of the channel entrance [29]. Meanwhile Shimizu also suggested a three-point binding 
model involving two hydrogen bonds with the ketal OHs, and ion pairing of the guanidinium group 
with an anionic site on the outside surface of the membrane [30]. With the success of cloning of the 
sodium channel [31], more precise information regarding the toxin-binding mode has arisen from the 
molecular biological studies of the sodium channel. PSP toxins are now regarded as blocking agents 
that reduce the number of conducting Na+ channels by occupying some site near the outer opening in a 
1:1 high affinity specific receptor binding. The extracellular loop sections of S1-S2 (P-loops) of the 
Na+ channel are considered to be the PSP toxins-binding site. They bind to the site on the 
voltage-dependent sodium channel with high affinity (Kd~2nM), which inhibits the temporary 
permeability of Na+ ions by binding tightly to receptor site 1 on the outside surface of the membrane 
very close to the external orifice of the sodium channel, preventing sodium ions from passing through 
the membranes of the nerve cells, and thus interfering with the transmission of signals along the nerves. 
The resulting widespread blockade prevents impulse-generation in peripheral nerves and skeletal 
muscles. Saxitoxin also affects skeletal muscle directly by blocking the muscle action potential without 
depolarizing cells, which abolishes peripheral nerve conduction but with no curare-like action at the 
neuromuscular junction. Surprisingly, selective pressure from the presence of STX in the natural 
environment can select for mutations in the ion selectivity filter that cause resistance to these toxins in 
the softshell clam Mya arenaria [32]. 
4. Neurotoxic Shellfish Poisoning (NSP) 
NSP is caused by the ingestion of shellfish exposed to blooms of the dinoflagellate Kerenia brevis 
(formerly Gymnodinium breve) [33, 34]. This dinoflagellate species produces two types of lipid 
soluble toxins: hemolytic and neurotoxic [35], causing massive fish kills, bird deaths, and marine 
mammal mortalities [36, 37]. The neurotoxic toxins are known as brevetoxins, which are a suite of 
ladder-like polycyclic ether toxins. Brevetoxin congeners are of two types based on backbone structure: 
brevetoxin B backbone (type 1; PbTx-2, 3, 5, 6, 8, 9) and brevetoxin A backbone (type 2; PbTx-1, 7, 
10) (Figure 3). Among them, PbTx-2T is the major brevetoxin produced by K. brevis [38]. Massive 
fishes are killed due to neurotoxin exposure, with the possible contribution of the hemolytic fraction. 
Recently neurotoxins were also found in other fish-killing flagellate species, Chatonella marina, C. 
antiqua, Fibrocapsa japonica, and Heterosigma akashiwo [39-41]. 
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Figure 3. Structure and species of neurotoxic shellfish poisoning toxins from marine 
dinoflagellates [4]. 
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Toxin Type R1 R2 
Nominal 
mass 
PbTx-1 2 H CH2C(CH2)CHO 866 
PbTx-2 1 H CH2C(CH2)CHO 894 
PbTx-3 1 H CH2C(CH2)CH2OH 896 
PbTx-5 1 COCH3 K-ring acetate PbTx-2 936 
PbTx-6 1 H H-ring epoxide PbTx-2 910 
PbTx-7 2 H CH2C(CH2)CH2OH 868 
PbTx-8 1 H CH2COCH2Cl 916 
PbTx-9 1 H CH2CH(CH3)CH2OH 898 
PbTx-10 2 H CH2CH(CH3)CH2OH 870 
 
As with many of the known marine toxins, the brevetoxins are tasteless, odorless, and heat and acid 
stable (they survive heat up to 300°C). The mouse LD50 is 170 µg/kg body weight (0.15–0.27) 
intraperitoneally, 94 µg/kg body weight intravenously and 520 µg/kg body weight orally [42]. 
Pathogenic dose for humans is in the order of 42-72 mouse units. NSP presents itself as a milder 
gastroenteritis with neurologic symptoms compared with PSP. The symptoms of NSP include nausea, 
tingling and numbness of the perioral area, loss of motor control, and severe muscular pain [43, 44]. 
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The mechanism of action of brevetoxins has been extensively studied, and brevetoxins are regarded 
as depolarizing substances that open voltage gated sodium ion channels in cell walls, leading to 
uncontrolled Na+ influx into the cell [45]. Experiments utilizing neuroblastoma cells and rat 
synaptosomes have shown that brevetoxins act on neurotoxin binding site 5 on the α-subunit of the 
voltage-dependent sodium channel in a 1:1 stoichiometry [46]. This action differs from that of PSP 
toxins which block the sodium channel and prevent sodium ions from passing through the membranes 
of nerve cells. This enhances the inward flow of Na+ ions into the cell by altering the membrane 
properties of excitable cell types, resulting in inappropriate opening of the channel under conditions in 
which it is normally closed, and it also inhibits channel inactivation [36, 45, 47-49]. The toxin appears 
to produce its sensory symptoms by transforming fast sodium channels into slower ones, which results 
in persistent activation and repetitive firing [50]. It was reported that brevetoxin could combine with a 
separate site on the gates of the sodium channel, causing the release of neurotransmitters from 
autonomic nerve endings. In particular, this can release acetylcholine, leading to smooth tracheal 
contraction, as well as massive mast cell degranulation [51]. Recently, LePage et al. demonstrated that 
brevetoxins also triggered Ca influx in rat cerebellar granule neurons. Derivatives PbTx-1, PbTx-2 and 
PbTx-3 produced a rapid and concentration-dependent increase in cytosolic [Ca2+], indicating that 
brevetoxin analogues display a range of efficacies to neurotoxin site 2 ligands and are activators of 
neurotoxin site 5, with PbTx-1 being a full agonist and other derivatives acting as partial agonists [52]. 
An early investigation also reported that conformational variation of brevetoxins induces a significant 
change in the gross shape of the molecule, which results in the loss of binding affinity and toxicity of 
the brevetoxins [46] 
5. Ciguatera Fish Poisoning (CFP) 
CFP, which is the most commonly reported marine toxin disease in the world, is caused by 
consumption of contaminated coral reef fishes such as barracuda, grouper, and snapper [53, 54]. It is 
estimated that approximately 25,000 people are affected annually by ciguatoxins and CFP is regarded 
as a world health problem [54]. The origin of ciguatera toxins has been identified in a dinoflagellate 
species, Gambierdiscus toxicus, which originally produces maitotoxins (MTXs), the lipophilic 
precursors of ciguatoxin [55]. These precursors are biotransformed to ciguatoxins by herbivorous 
fishes and invertebrates grazing on G. toxicus and then accumulated in higher trophic levels [56]. The 
ciguatoxins are a family of heat-stable, lipid-soluble, highly oxygenated, cyclic polyether molecules 
with a structural framework reminiscent of the brevetoxins [57-60], and more than 20 toxins may be 
involved in CFP (Figure 4) [53].  
The biological activities of ciguatoxins have been studied extensively and they are regarded as the 
most potent activators of sodium and/or calcium fluxes in the cytoplasm in various cells. They produce 
more than 175 ciguateric symptoms, classified into four categories: gastrointestinal, neurological, 
cardiovascular and general symptoms [54, 61]. It should be emphasized that the symptoms of ciguatera 
vary in different oceans: in the Pacific Ocean neurological symptoms predominate, while in the 
Caribbean Sea the gastrointestinal symptoms dominate due to the difference in toxin composition. 
Ciguatoxin and maitotoxin are the two most common toxins associated with CFP, and they are the 
most lethal natural substances known. Pharmacological studies have revealed that CTXs activate the 
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voltage-sensitive sodium channel at nM to pM concentrations [61]. In mice, ciguatoxin is lethal at 0.45 
μg/kg ip, and maitotoxin at a dose of 0.15 μg/kg ip. Oral intake of as little as 0.1 μg ciguatoxin can 
cause illness in the human adult. 
Figure 4. Structure and species of ciguatoxins from the dinoflagellate G. toxicus [62]. 
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Ciguatoxins exert the same action mode as brevetoxins, which selectively target the common 
binding site 5 on the α-subunit of neuronal sodium channels. However, the affinity of ciguatoxins is 
higher than that of brevetoxins and, thus, the affinity of CTX-1 for voltage dependent sodium channels 
is around 30 times higher than that of brevetoxin. Ciguatoxins open sodium channels along the 
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peripheral nerves, particularly at the nodes of Ranvier [62, 63], which results in an influx of Na+ ions, 
cell depolarization and the appearance of spontaneous action potentials in excitable cells. Consequently, 
the plasma membrane is unable to maintain either the internal environment of the cells or volume 
control due to the increased Na+ permeability, which results in alteration of bioenergetic mechanisms, 
cell and mitochondrial swelling and bleb formation on cell surfaces. With neurophysiological testing, 
significant slowing of sensory and motor nerve conduction velocities, and F wave latencies has been 
demonstrated [62, 64, 65]. This observation may be related to nodal swelling and internodal length and 
volume increase, all of which have been confirmed with in vitro CTX exposure [63, 66]. 
Studies on cardiovascular effects of ciguatoxins reveal that ciguatoxin affects voltage-dependent 
Na+ channels causing Na+ to move intracellularly, and normal cellular mechanisms begin to extrude 
sodium and take up calcium. Calcium is the intracellular trigger for muscle contraction. Although 
much of the increased calcium is buffered by the sarcoplasmic reticulum, it is likely that locally 
increased calcium concentrations increase the force of cardiac muscle contraction as is observed in 
ciguatoxin poisoning. A similar mechanism of ciguatoxin-induced intracellular transport of calcium 
occurs in intestinal epithelial cells. The increased concentration of intracellular calcium induced by 
ciguatoxin acts as a second messenger in the cell, which disrupts important ion-exchange systems, 
resulting in fluid secretion and symptoms of diarrhea [67]. 
Figure 5. Structure of maitotoxin from the dinoflagellate G. toxicus [120]. 
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Maitotoxin, another important neurotoxin involved in CFP, is a water soluble, ladder-shaped 
polycyclic molecule with numerous hydroxyl groups and sulfate groups (Figure 5). Three forms of 
MTX, MTX-1, MTX-2 and MTX-3 have been identified from G. toxicus [68]. MTX has been proved 
to be the most potent toxin identified on a weight basis: the LD50 of MTX in mice is less than 0.2 
μg/Kg (intraperitoneally) and it is at least 5-fold more toxic than tetrodotoxin. Pharmacological studies 
demonstrate that MTX is a potent activator of voltage-gated calcium channels which stimulates the 
movement of Ca2+ ions across biomembranes in a wide variety of organisms. As a consequence of Ca2+ 
influx, maitotoxins can produce several effects: hormone and neurotransmitter secretion, 
phosphoinositides breakdown, and activation of voltage gated Ca2+ channels due to membrane 
depolarization. However, the primary target of MTX still remains undefined and the molecular 
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mechanism of action is not clear. It is postulated that MTX might cause a shift in voltage-dependence 
of gating that favors opening of voltage-gated calcium channels at resting membrane potentials. 
However, MTX activates voltage-gated calcium channels indirectly via membrane depolarization as a 
consequence of activating a nonselective cation current [69]. Recently, Kakizaki et al. reported that 
maitotoxin induced a profound increase in the Ca2+ influx into cultured brainstem cells after a brief lag 
period, indicating Ca2+ permeability by acting on the calcium channel in an open state and preventing 
its closing [70]. 
6. Azaspiracid Shellfish Poisoning (AZP) 
Azaspiracid poisoning (AZP), first reported from the Netherlands but later becoming a continuing 
problem in Europe [71], is a newly identified marine toxin disease. It is caused by consumption of 
contaminated shellfish associated with the dinoflagellate Protoperidinium crassipes, which can 
produce high intracellular concentrations of azaspiracid (AZA1), a lipophilic, polyether toxin. 
Nowadays about one dozen derivatives (AZA2 to 11) of azaspiracid (AZA1) have been identified and 
characterized from P. crassipes and contaminated shellfish [72-74]. AZAs differ significantly from 
other dinoflagellate toxins, in that they have unique structural features characterized by a tri-spiro 
assembly, an azazpiro ring fused with a 2,9-dinoxabicyclo[3.3.1] nonane and a terminal carboxylic 
acid group (Figure 6). 
Figure 6. Structure and species of azaspiracid poisoning toxins from marine 
dinoflagellates [121]. 
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The symptoms of AZP include nausea, vomiting, severe diarrhea and stomach cramps. Neurotoxic 
symptoms were also observed [72, 75, 76]. However, the extremely limited availability of the pure 
toxins has impeded the necessary investigations of AZP. Some experiments carried out with mice 
showed that AZP, unlike okadaic acid (OA) and its analog, dinophysistoxin-1, which need an initiator 
[77], can cause lung tumor formation during repeated administration or after withdrawal of AZP 
without the combined use of any initiator [78]. Also the toxin can cause necrosis in the lamina propria 
of the small intestine and in lymphoid tissues such as the thymus, spleen and Peyer's patches [78]. The 
action mechanism of AZAs is unknown at present. Some studies indicate that AZAs might have 
different targets, since AZA1 and AZA2 increase [Ca2+]i by activation of Ca2+ -release from internal 
stores and Ca2+-influx, while AZA3 induces only Ca2+-influx. AZA5 does not modify intracellular Ca2+ 
homeostasis. Recent investigation of the effect of AZA4 on cytosolic calcium concentration [Ca2+]i in 
fresh human lymphocytes demonstrated that AZA4 inhibits store-operated Ca2+ channels (SOC 
channels) and Ca2+ influx and that this process is reversible [76]. It was postulated that AZA4 inhibits 
SOC channels by direct interaction with the channel pore, with another region of channel protein or 
with a closely associated regulatory protein and it was also found that AZA4 acts through another type 
of Ca2+ channel, probably some non selective cation channel usually activated by MTX [76]. AZA 
groups are novel inhibitors of Ca2+ channels, SOC and non-SOC channels. Further study is needed to 
determine the primary target and the molecular mechanisms of action of AZAs on Ca2+ channels. 
7. Yessotoxin (YTX) 
YTX and it analogues, which are disulphated polyether compounds of increasing occurrence in 
seafood, were originally isolated from the scallop Patinopecten yessoensis, collected at Mutsu Bay, 
Japan [79]. Since then, YTXs have been found in Europe, South America and New Zealand, and 
become a worldwide concern due to its potential risk to human health. YTXs were produced by three 
dinoflagellate species, Protoceratium reticulatum, Lingulodinium polyedrum and Gonyaulax spinifera 
[80-83].  
YTX and its derivatives, 45-hydroxy YTX (45-OH-YTX), 45,46,47-trinor YTX, homo YTX, and 
45-hydroxyhomo YTX [84, 85] are disulfated polyether lipophilic toxins originally isolated from 
Japanese scallops (Figure 7) [80]. Recently several new YTX analogues: carboxyyessotoxin (with a 
COOH group on the C44 of YTX instead of a double bond); carboxyhomoyessotoxin (with a COOH 
group on the C44 of homoYTX instead of a double bond); 42,43,44,45,46,47,55-heptanor-41-oxo YTX 
and 42,43,44,45,46,47,55-heptanor-41-oxohomo YTX in Adriatic mussels (M. galloprovincialis) have 
been identified in dinoflagellates [86, 87]. 
Originally, YTXs were classified among the toxins responsible for DSP, mainly because they 
appear and are extracted together with the DSP toxins, OA and the dinophysistoxins (DTXs) [80]. 
However, YTXs are proved to be not diarrheogenic compared to OA and its derivatives, the DTXs, 
which cause intestinal fluid accumulation or inhibition of protein phosphatase 2A. Terao et al. 
demonstrated that the heart is the main target organ of YTXs in mice [88]. Toxicological studies 
indicated that acute oral administration at doses up to 10 mg/kg YTX or repeated (seven days) oral 
exposure to high (2 mg/kg/day) doses of the toxin caused no mortality nor strong signs of toxicity in 
mice [89-91]. YTX caused motor discoordination in the mouse before death due to cerebellar cortical 
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alterations [90, 92, 93]. Histopathological study revealed that YTX provoked alterations in the Purkinje 
cells of the cerebellum, including cytological damage to the neuronal cell body and change in the 
neurotubule and neurofilament immunoreactivity [93].  
 
Figure 7. Structure and species of yessotoxins from marine dinoflagellates [122]. 
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Recently it was demonstrated that YTX is a potent neurotoxin to neuronal cells. However, the 
action site and the mechanism are unknown [94]. YTX was observed to induce a two-fold increase in 
cytosolic calcium in cerebellar neurons that was prevented by the voltage-sensitive calcium channel 
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antagonists nifedipine and verapamil. These results suggest YTX might interact with calcium channels 
and/or sodium channels directly. Previous studies also showed that YTX activated nifedipine-sensitive 
calcium channels in human lymphocytes [95], and YTX was postulated to activate non-capacitative 
calcium entry and inhibit capacitive calcium entry by emptying of internal calcium stores. 
8. Palytoxin (PTX) 
PTX is a polyhydroxylated compound that shows remarkable biological activity at an extremely 
low concentration [96]. This toxin was first isolated from the soft coral Palythoa toxica and 
subsequently from many other organisms such as seaweeds and shellfish. Recently, palytoxin was also 
found in a benthic dinoflagellate, Ostrepsis siamensis, which caused blooms along the coast of Europe 
[97-102], extensive death of edible mollusks and echinoderms [99, 100] and human illnesses [98, 99]. 
Cases of death resulting from PTX have been reported to be due to consumption of contaminated crabs 
in the Philippines [103], sea urchins in Brazil [104] and fish in Japan [105-107]. PTX has become of 
worldwide concern due to its potential impact on animals including humans.  
PTX is a large, very complex molecule with both lipophilic and hydrophilic regions, and has the 
longest chain of continuous carbon atoms in any known natural product (Figure 8). Recently several 
analogues, ostreocin-D (42-hydroxy-3, 26-didemethyl-9,44-dideoxypalytoxin) and mascarenotoxins 
were identified in O. siamensis. PTX is regarded as one of the most potent toxins so far known [108], 
the LD50s 24 h after intravenous injection vary from 0.025 μg/kg in rabbits and about the same in dogs 
to 0.45 μg/kg in mice, with monkeys, rats and guinea pigs around 0.9 μg/kg. Toxic symptoms include 
fever inaction, ataxia, drowsiness, and weakness of limbs followed by death. 
Over the past few decades much effort has been devoted to define the action mechanisms of PTXs, 
however these have not been identified. Pharmacological and electrophysiological studies have 
demonstrated that PTXs act as a haemolysin and alter the function of excitable cells. PTX selectively 
binds to the Na+, K+-ATPase with a Kd of 20 pM [109] and transforms the pump into a channel 
permeable to monovalent cations with a single-channel conductance of 10 pS [110–113]. Presently, 
three primary sites of action of PTXs have been postulated: PTX first opens a small conductance, 
non-selective cationic channel which results in membrane depolarization, K+ efflux and Na+ influx. 
Subsequently, the membrane depolarization may open voltage dependent Ca2+ channels in synaptic 
nerve terminals, cardiac cells and smooth muscle cells, while Na+ influx may load cells with Na+ and 
favor Ca2+ uptake by the Na+/Ca2+ exchanger in synaptic terminals, cardiac cells and vascular smooth 
muscle cells. Then the increase of [Ca2+li stimulates the release of neurotransmitters by nerve terminals, 
of histamine by mast cells and of vasoactive factors by vascular endothelial cells as a signal. It also 
induces contractions of striated and smooth muscle cells. Additional effects of a rise in [Ca2+]i may be 
activation of phospholipase C [114] and phospholipase A2 [115]. There are reports that PTX opens an 
H+ conductive pathway which results in activation of the Na+/H+ exchanger [116, 117]. Other 
investigators suggest that PTX raises [Ca2+]i independently of the activity of voltage dependent Ca2+ 
channels and Na+/Ca’+ exchange [118]. The last two actions might act as the opening of H+ specific 
and Ca2+ specific channels. Overall, PTX might posses more than one site of action in excitable cells 
and act as an agonist for low conductance channels conducting Na+/K+, Ca2+ and H+ ions. 
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Figure 8. Structure of palytoxin from marine dinoflagellates [123]. 
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9. Summary 
This paper briefly outlines the origin, structure, symptoms and molecular action mechanisms of 
neurotoxins produced by marine dinoflagellates. These toxins vary in chemical structure and 
mechanism of action, and produce very distinct biological effects, which provides a potential 
application of these toxins in pharmacology and toxicology. However, some of them have not been 
well studied due to the limited supply of pure toxins and their molecular action mechanisms are 
unknown. Moreover, novel species of neurotoxins produced by dinoflagellates have been found and 
identified, which provide a challenge for the characterization of their toxin mechanisms and their 
effects on marine organisms and humans. Further work using the cell-based approach is needed to 
determine the precise mode of action of these novel neurotoxins from marine dinoflagellates. 
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